Radiofrequency DNA Damage Literature Review Presentation

April 3, 2022

Steven Weller (PhD Candidate, BSc. MORSAA, MARPS). Australian Radiation Protection Society (ARPS) Conference
Canberra – March 2022

Controversial findings and issues
• Results demonstrate a real risk for genotoxicity, particularly chronic long term exposures
• Because we are blanketing the earth with RF, all species are at risk
• Balance of probability also supports a case for carcinogenicity
• ARPANSA and ICNIRP do not consider these risks, they look for confirmed evidence of harm
• New wireless technology is being rolled out without pre-market health testing
• Safety is assumed if operating within public limits
• Precaution is absent, with ARPANSA explicitly removing precautionary principle that was present in RPS 3 from the latest RF Standard (RPS S-1)

Future Research Recommendations
• Experiments should be conducted that approximate typical real life exposures
• Use exposure regimes > 48 hours in accumulated duration
• Real wireless devices should be used
• Include assays for both DNA damage and free radical production
• Assays should be taken at different intervals to measure changes over time
• PCR tests to verify gene expression changes (DNA repair genes, OS genes)
• Multiple exposures rather than a single continuous exposure
• Controlled experiments should contrast constant exposure intensity with variable intensities over the same time period

Full presentation can be found here:

Donate To Support Us

Not for Profit Organisation

STANZ is a not-for-profit organisation which relies on the good will of its members to run its operations. The only source of funding it currently receives are from donations from members and the public.

STANZ has an elected Coordinating Committee that meets regularly to organise the affairs and activities of the society.

Related Articles

Follow Us

Social Media to keep up to date with the latest news and views


Support STANZ in its Mission to make Aotearoa New Zealand safe for people and the environment

Join Our Newsletter

Keep up to date with our quarterly newsletter summarising the most important news, views and campaign actions